查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1756389

细胞和基因治疗生物分析测试服务市场，按产品类型、按测试类型、按技术、按适应症覆盖范围、按最终用户、按国家/地区 - 2025 年至 2032 年全球行业分析、市场规模、市场份额和预测

Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type, By Test Type, By Technology, By Indication Coverage, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 316 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年细胞和基因治疗生物分析测试服务市场规模价值 5.609 亿美元，2025 年至 2032 年的复合年增长率为 7.90%。

细胞和基因治疗生物分析测试服务市场-市场动态

临床试验数量增加和监管审查力度加大，加速市场扩张

临床试验活动的激增和监管机构对先进疗法的日益关注，显着增加了对细胞和基因治疗生物分析测试服务的需求。 2023 年，美国 FDA 批准了超过 25 项基因疗法的新药临床试验申请 (IND)，反映出正在评估的疗法数量众多。此外，欧洲药品管理局 (EMA) 和日本药品医疗器材综合机构 (PMDA) 等监管机构也越来越多地要求进行全面的生物分析验证，以确保安全性和有效性。美国国立卫生研究院 (NIH) 和加州再生医学研究所 (CIRM) 等组织增加了对基因和细胞试验的资助，间接刺激了对专业测试服务的需求。这些趋势强调了高精度分析平台在确保资料完整性方面的关键作用，这对于治疗成功和市场授权至关重要，尤其是在监管日益严格和创新驱动的环境中。

细胞和基因治疗生物分析测试服务市场-关键见解

根据我们的研究分析师的分析，预测期内（2025-2032 年）全球市场预计年复合成长率约为 7.90%

根据产品类型细分，预计细胞疗法将在 2024 年占据最大市场份额

根据测试类型细分，生物利用度和生物等效性是 2024 年领先的测试类型

根据技术细分，次世代定序 (NGS) 是 2024 年的领先技术

根据适应症覆盖范围细分，肿瘤癌症是 2024 年领先的适应症覆盖范围

根据最终用户细分，生物技术和製药公司是 2024 年领先的最终用户

按地区划分，北美是 2024 年的主要收入来源

细胞和基因治疗生物分析测试服务市场-細項分析：

全球细胞和基因疗法生物分析测试服务市场根据产品类型、测试类型、技术、适应症覆盖范围、最终用户和地区进行细分。

根据产品类型，市场分为三类：细胞疗法、基因疗法（体外和体内）以及基因修饰细胞疗法（CAR-T细胞疗法、CAR-NK细胞疗法、TCR-T细胞疗法）。细胞疗法服务着重于干细胞和免疫细胞的效力、身份和安全性测试。基因疗法分为体外和体内两种模式，需要进行病毒载体和转导效率分析。 CAR-T、CAR-NK和TCR-T等基因修饰细胞疗法着重于工程化免疫反应进行生物分析验证。

根据测试类型，市场分为八类：生物利用度和生物等效性研究、药物动力学测试、药效动力学测试、生物标记测试、非临床、组织生物分析、杂项和其他。生物利用度和生物等效性研究确保治疗的一致性，而药物动力学和药效动力学测试则评估吸收和药物作用。生物标记测试支持疗效追踪，非临床和组织生物分析则有助于临床前洞察。杂项和其他测试提供支持性、针对特定病例的分析资料。

细胞和基因治疗生物分析测试服务市场-地理洞察

细胞与基因疗法生物分析测试服务市场呈现显着的地理差异，受各地区疗法开发速度、监管框架和研发资金的影响。北美凭藉其先进的生物技术中心、强大的政府支持以及创新疗法的早期应用，在市场份额方面处于领先地位。尤其是美国，它拥有密集的基因和细胞治疗开发商网络，并制定了诸如FDA加速途径等监管框架，鼓励临床扩展。欧洲紧随其后，德国、英国和荷兰等国家正在投资建造GMP认证实验室和国家细胞治疗计画。亚太地区正迅速崛起，成为一个强有力的竞争者，尤其是在中国、韩国和日本，这些国家政府支持的生物科技园区和不断扩大的临床基础设施支撑着市场的成长。印度和新加坡日益增长的外包趋势也在重塑区域服务格局，使亚洲成为经济高效的生物分析测试服务的战略中心。

细胞和基因治疗生物分析测试服务市场-竞争格局：

细胞与基因治疗生物分析测试服务市场的竞争格局以全球合约研究组织 (CRO)、专业测试实验室以及专注于提升复杂生物製剂分析能力的新兴生物技术服务提供者为标誌。主要参与者正在投资最先进的设施、GLP/GMP 认证实验室和专有检测平台，以满足日益增长的监管和科研需求。疗法开发商与 CRO 之间的合作日益增多，旨在简化流程并确保从临床前阶段到临床开发阶段的合规性。各公司正在扩展服务组合，涵盖客製化效力检测、生物分布研究、载体表征以及基于新一代定序的分析。此外，学术实验室和医院附属实验室正在为早期方法开发和标准化做出贡献。在亚太等地区，竞争也日益激烈，当地公司正在扩大全球试验服务，使灵活性、监管专业知识和周转时间成为这一不断变化的格局中的关键差异化因素。

最新动态：

2024 年 8 月，SGS 在北美推出了针对细胞和基因治疗的专业生物分析测试服务，在其位于新罕布夏州哈德逊的实验室提供从发现到 3 期临床试验的全面解决方案，扩大了先进治疗开发和法规遵从性的全球能力。

2025年3月，Bharat Biotech在特伦甘纳邦启动了其首个细胞和基因治疗设施，投资7,500万美元。该公司的目标是在2028年推出针对肿瘤和罕见疾病的新型细胞和基因疗法，重点是可负担性，并拓展疫苗以外的领域。

2025 年 4 月，Cell Therapies 和 Xellera Therapeutics 合作加速亚太地区细胞和基因治疗的获取，重点关注澳洲和香港的 GMP 製造、监管解决方案和协作创新，旨在加强患者护理并简化市场准入。

目录

第一章：细胞和基因治疗生物分析测试服务市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • 细胞和基因治疗生物分析测试服务市场片段（按产品类型）
    • 细胞和基因治疗生物分析测试服务市场片段（按测试类型）
    • 细胞和基因治疗生物分析测试服务市场片段（按技术）
    • 细胞和基因治疗生物分析测试服务市场片段（按适应症覆盖范围）
    • 细胞和基因治疗生物分析测试服务市场片段（按最终用户）
    • 细胞和基因治疗生物分析测试服务市场（按国家/地区）
    • 细胞和基因治疗生物分析测试服务市场片段（按地区）
  • 竞争洞察

第三章：细胞和基因治疗生物分析测试服务主要市场趋势

  • 细胞和基因治疗生物分析测试服务市场驱动因素
    • 市场驱动因素的影响分析
  • 细胞和基因治疗生物分析测试服务市场限制
    • 市场限制的影响分析
  • 细胞和基因治疗生物分析测试服务市场机会
  • 细胞和基因治疗生物分析测试服务市场未来趋势

第四章：细胞与基因治疗生物分析测试服务业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：细胞与基因治疗生物分析测试服务市场：地缘政治紧张局势升级的影响

  • COVID-19 疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：细胞与基因治疗生物分析测试服务市场格局

  • 细胞和基因治疗生物分析测试服务市场份额分析（2024年）
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：细胞和基因治疗生物分析测试服务市场 - 按产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 细胞疗法
    • 基因治疗
      • 离体
      • 体内
    • 基因改造细胞疗法
      • CAR-T细胞疗法
      • CAR-NK细胞疗法
      • TCR-T细胞疗法

第八章：细胞和基因治疗生物分析测试服务市场 - 按测试类型

  • 概述
    • 按测试类型分類的细分市场份额分析
    • 生物利用度和生物等效性研究
    • 药物动力学测试
    • 药效动力学测试
    • 生物标记检测
    • 非临床
    • 组织生物分析
    • 各种各样的
    • 其他的

第九章：细胞和基因治疗生物分析测试服务市场 - 按技术

  • 概述
    • 按技术细分的市场份额分析
    • 聚合酶连锁反应
    • 酵素连结免疫吸附试验
    • 下一代定序（NGS）
    • 流式细胞仪
    • 其他的

第 10 章：细胞和基因治疗生物分析测试服务市场 - 按适应症覆盖范围

  • 概述
    • 按适应症覆盖率分析细分市场份额
    • 肿瘤学 癌症
    • 传染病
    • 神经系统疾病
    • 心血管疾病
    • 胃肠道疾病
    • 自体免疫疾病
    • 罕见疾病
    • 其他的

第 11 章：细胞和基因治疗生物分析测试服务市场 - 按最终用户

  • 概述
    • 按最终用户细分的份额分析
    • 生技与製药公司
    • 学术及研究机构
    • 合约研究组织（CRO）

第 12 章：细胞和基因治疗生物分析测试服务市场-按地区

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美细胞和基因治疗生物分析测试服务主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按测试类型）
    • 北美市场规模和预测（按技术）
    • 北美市场规模及预测（按适应症覆盖范围）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲细胞和基因治疗生物分析测试服务主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按测试类型）
    • 欧洲市场规模与预测（按技术）
    • 欧洲市场规模及预测（依适应症覆盖）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区细胞和基因治疗生物分析测试服务主要製造商
    • 亚太地区市场规模及预测（依国家）
    • 亚太地区市场规模及预测（依产品类型）
    • 亚太地区市场规模及预测（依测试类型）
    • 亚太地区市场规模及预测（依技术）
    • 亚太地区市场规模及预测（依适应症覆盖范围）
    • 亚太地区市场规模及预测（依最终用户）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲细胞和基因治疗生物分析测试服务主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（依产品类型）
    • 拉丁美洲市场规模及预测（按测试类型）
    • 拉丁美洲市场规模及预测（按技术）
    • 拉丁美洲市场规模及预测（依适应症覆盖范围）
    • LATAM 规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲细胞和基因治疗生物分析测试服务主要製造商
    • 中东和非洲市场规模及预测（按国家/地区）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按测试类型）
    • 中东和非洲市场规模及预测（按技术）
    • 中东和非洲市场规模及预测（按适应症覆盖范围）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 13 章：关键供应商分析-细胞和基因治疗生物分析测试服务产业

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Alliance Pharma
    • BioAgilytix Labs
    • Charles River Laboratories
    • Clean Cells
    • Covance Inc.
    • Eurofins Scientific
    • ICON plc
    • Intertek Group Plc
    • IQVIA, Inc.
    • KCAS Bioanalytical Services
    • Laboratory Corporation of America Holdings
    • Pharmaceutical Product Development, Inc. (Thermo Fisher Scientific Inc.)
    • Pharmaron
    • Prolytix
    • SGS SA
    • Syneos Health
    • Others

第 14 章：360 度分析师视角

第 15 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5304

REPORT HIGHLIGHT

Cell & Gene Therapy Bioanalytical Testing Services Market size was valued at US$ 560.90 Million in 2024, expanding at a CAGR of 7.90% from 2025 to 2032.

The Cell & Gene Therapy Bioanalytical Testing Services Market encompasses specialized analytical services that support the development, characterization, and regulatory approval of cell and gene therapy products. Growth in this market is propelled by the rising number of clinical trials in regenerative medicine and personalized therapeutics. For instance, as of early 2024, the FDA had over 2,000 active Investigational New Drug applications for gene and cell therapy products. Increasing investments from public health bodies, like the NIH's \$500 million commitment to advance gene therapy for rare diseases, further bolster demand. However, the complexity of assay development and high operational costs remain key restraints. Opportunities lie in expanding testing capabilities for viral vectors, potency assays, and biodistribution studies, especially as global regulatory agencies tighten guidelines for cell-based therapies. Additionally, partnerships between biopharma and CROs are streamlining bioanalytical workflows to enhance speed-to-market for next-gen therapies.

Cell & Gene Therapy Bioanalytical Testing Services Market- Market Dynamics

Rising Clinical Trial Volume and Regulatory Scrutiny to Accelerate Market Expansion

The surge in clinical trial activity and growing regulatory focus on advanced therapies have significantly intensified the demand for cell and gene therapy bioanalytical testing services. In 2023, the U.S. FDA approved over 25 Investigational New Drug (IND) applications for gene therapies, reflecting the robust pipeline of therapies under evaluation. Furthermore, regulatory bodies like the European Medicines Agency (EMA) and the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan are increasingly mandating comprehensive bioanalytical validation for safety and efficacy assurance. Organizations such as the NIH and CIRM (California Institute for Regenerative Medicine) have increased funding for gene and cell-based trials, indirectly fueling demand for specialized testing services. These trends emphasize the critical role of high-precision analytical platforms in ensuring data integrity, which is vital for therapeutic success and market authorization, particularly in a landscape that is becoming more regulated and innovation-driven.

Cell & Gene Therapy Bioanalytical Testing Services Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.90% over the forecast period (2025-2032)

Based on product type segmentation, Cell therapy was predicted to show maximum market share in the year 2024

Based on Test Type segmentation, Bioavailability & bioequivalence was the leading Test Type in 2024

Based on Technology segmentation, Next-Generation Sequencing (NGS) was the leading Technology in 2024

Based on Indication Coverage segmentation, Oncology Cancer was the leading Indication Coverage in 2024

Based on end user segmentation, Biotechnology & Pharmaceutical Companies were the leading end user in 2024

On the basis of region, North America was the leading revenue generator in 2024

Cell & Gene Therapy Bioanalytical Testing Services Market- Segmentation Analysis:

The Global Cell & Gene Therapy Bioanalytical Testing Services Market is segmented on the basis of Product Type, Test Type, Technology, Indication Coverage, End User, and Region.

The market is divided into three categories based on product type: Cell Therapy, Gene Therapy (Ex-vivo, and In-vivo), and Gene-Modified Cell Therapy (CAR T-cell therapies, CAR-NK cell therapy, TCR-T cell therapy). Cell therapy services focus on potency, identity, and safety testing for stem and immune cells. Gene therapy is segmented into ex-vivo and in-vivo modalities, requiring viral vector and transduction efficiency assays. Gene-modified cell therapies like CAR T, CAR-NK, and TCR-T emphasize bioanalytical validation for engineered immune responses.

The market is divided into eight categories based on Test Type: Bioavailability & Bioequivalence Studies, Pharmacokinetic Testing, Pharmacodynamic Testing, Biomarker Testing, Non-clinical, Tissue Bioanalysis, Miscellaneous, and Others. Bioavailability & bioequivalence studies ensure therapeutic consistency, while pharmacokinetic and pharmacodynamic testing assess absorption and drug action. Biomarker testing supports efficacy tracking, and non-clinical and tissue bioanalysis aid preclinical insights. Miscellaneous and other tests provide supportive, case-specific analytical data.

Cell & Gene Therapy Bioanalytical Testing Services Market- Geographical Insights

The Cell & Gene Therapy Bioanalytical Testing Services Market shows significant geographical variation, driven by the pace of therapy development, regulatory frameworks, and R&D funding across regions. North America leads in market share due to the presence of advanced biotechnology hubs, strong government support, and early adoption of innovative therapies. The U.S., in particular, has a dense network of gene and cell therapy developers and regulatory frameworks such as the FDA's accelerated pathways, encouraging clinical expansion. Europe follows closely, with countries like Germany, the UK, and the Netherlands investing in GMP-certified labs and national cell therapy initiatives. Asia-Pacific is rapidly emerging as a strong contender, especially in China, South Korea, and Japan, where government-backed biotech parks and expanding clinical infrastructure support growth. Increasing outsourcing trends in India and Singapore are also reshaping the regional service landscape, making Asia a strategic hub for cost-effective bioanalytical testing services.

Cell & Gene Therapy Bioanalytical Testing Services Market- Competitive Landscape:

The competitive landscape of the Cell & Gene Therapy Bioanalytical Testing Services Market is marked by the presence of global contract research organizations (CROs), specialized testing labs, and emerging biotech service providers focused on advancing analytical capabilities for complex biologics. Key players are investing in state-of-the-art facilities, GLP/GMP-certified labs, and proprietary assay platforms to meet growing regulatory and scientific demands. Collaborations between therapy developers and CROs are increasing, aiming to streamline timelines and ensure regulatory compliance from preclinical stages through clinical development. Companies are expanding service portfolios to include customized potency assays, biodistribution studies, vector characterization, and next-generation sequencing-based analytics. Moreover, academic and hospital-affiliated labs are contributing to early-stage method development and standardization. Competition is also intensifying in regions like Asia-Pacific, where local firms are scaling up offerings for global trials, making flexibility, regulatory expertise, and turnaround time key differentiators in this evolving landscape.

Recent Developments:

In August 2024, SGS launched specialized bioanalytical testing services for cell and gene therapy in North America, offering comprehensive solutions from discovery to phase 3 clinical trials at its Hudson, New Hampshire lab, expanding global capabilities for advanced therapeutic development and regulatory compliance.

In March 2025, Bharat Biotech launched its first cell and gene therapy facility in Telangana, investing $75 million. The company aims to introduce novel cell and gene therapies for oncology and rare diseases by 2028, focusing on affordability and expanding beyond vaccines.

In April 2025, Cell Therapies and Xellera Therapeutics partnered to accelerate cell and gene therapy access across Asia-Pacific, focusing on GMP manufacturing, regulatory solutions, and collaborative innovation in Australia and Hong Kong, aiming to enhance patient care and streamline market access.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CELL & GENE THERAPY BIOANALYTICAL TESTING SERVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Alliance Pharma
  • BioAgilytix Labs
  • Charles River Laboratories
  • Clean Cells
  • Covance Inc.
  • Eurofins Scientific
  • ICON plc
  • Intertek Group Plc
  • IQVIA, Inc.
  • KCAS Bioanalytical Services
  • Laboratory Corporation of America Holdings
  • Pharmaceutical Product Development, Inc. (Thermo Fisher Scientific Inc.)
  • Pharmaron
  • Prolytix
  • SGS SA
  • Syneos Health
  • Others

GLOBAL CELL & GENE THERAPY BIOANALYTICAL TESTING SERVICES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Cell Therapy
  • Gene Therapy
  • Ex-vivo
  • In-vivo
  • Gene-Modified Cell Therapy
  • CAR T-cell therapies
  • CAR-NK cell therapy
  • TCR-T cell therapy

GLOBAL CELL & GENE THERAPY BIOANALYTICAL TESTING SERVICES MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Bioavailability & Bioequivalence Studies
  • Pharmacokinetic Testing
  • Pharmacodynamic Testing
  • Biomarker Testing
  • Non-clinical
  • Tissue Bioanalysis
  • Miscellaneous
  • Others

GLOBAL CELL & GENE THERAPY BIOANALYTICAL TESTING SERVICES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • PCR
  • ELISA
  • Next-Generation Sequencing (NGS)
  • Flow Cytometry
  • Others

GLOBAL CELL & GENE THERAPY BIOANALYTICAL TESTING SERVICES MARKET, BY INDICATION COVERAGE- MARKET ANALYSIS, 2019 - 2032

  • Oncology Cancer
  • Infectious Diseases
  • Neurological disorders
  • Cardiovascular Disorders
  • Gastrointestinal Diseases
  • Autoimmune Diseases
  • Rare Diseases
  • Others

GLOBAL CELL & GENE THERAPY BIOANALYTICAL TESTING SERVICES MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Biotechnology & Pharmaceutical Companies
  • Academic & Research Institutes
  • Contract Research Organizations (CROs)

GLOBAL CELL & GENE THERAPY BIOANALYTICAL TESTING SERVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cell & Gene Therapy Bioanalytical Testing Services Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cell & Gene Therapy Bioanalytical Testing Services Market Snippet by Product Type
    • 2.1.2. Cell & Gene Therapy Bioanalytical Testing Services Market Snippet by Test Type
    • 2.1.3. Cell & Gene Therapy Bioanalytical Testing Services Market Snippet by Technology
    • 2.1.4. Cell & Gene Therapy Bioanalytical Testing Services Market Snippet by Indication Coverage
    • 2.1.5. Cell & Gene Therapy Bioanalytical Testing Services Market Snippet by End User
    • 2.1.6. Cell & Gene Therapy Bioanalytical Testing Services Market Snippet by Country
    • 2.1.7. Cell & Gene Therapy Bioanalytical Testing Services Market Snippet by Region
  • 2.2. Competitive Insights

3. Cell & Gene Therapy Bioanalytical Testing Services Key Market Trends

  • 3.1. Cell & Gene Therapy Bioanalytical Testing Services Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cell & Gene Therapy Bioanalytical Testing Services Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cell & Gene Therapy Bioanalytical Testing Services Market Opportunities
  • 3.4. Cell & Gene Therapy Bioanalytical Testing Services Market Future Trends

4. Cell & Gene Therapy Bioanalytical Testing Services Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cell & Gene Therapy Bioanalytical Testing Services Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Cell & Gene Therapy Bioanalytical Testing Services Market Landscape

  • 6.1. Cell & Gene Therapy Bioanalytical Testing Services Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cell & Gene Therapy Bioanalytical Testing Services Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Cell Therapy
    • 7.1.3. Gene Therapy
      • 7.1.3.1. Ex-vivo
      • 7.1.3.2. In-vivo
    • 7.1.4. Gene-Modified Cell Therapy
      • 7.1.4.1. CAR T-cell therapies
      • 7.1.4.2. CAR-NK cell therapy
      • 7.1.4.3. TCR-T cell therapy

8. Cell & Gene Therapy Bioanalytical Testing Services Market - By Test Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
    • 8.1.2. Bioavailability & Bioequivalence Studies
    • 8.1.3. Pharmacokinetic Testing
    • 8.1.4. Pharmacodynamic Testing
    • 8.1.5. Biomarker Testing
    • 8.1.6. Non-clinical
    • 8.1.7. Tissue Bioanalysis
    • 8.1.8. Miscellaneous
    • 8.1.9. Others

9. Cell & Gene Therapy Bioanalytical Testing Services Market - By Technology

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 9.1.2. PCR
    • 9.1.3. ELISA
    • 9.1.4. Next-Generation Sequencing (NGS)
    • 9.1.5. Flow Cytometry
    • 9.1.6. Others

10. Cell & Gene Therapy Bioanalytical Testing Services Market - By Indication Coverage

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Indication Coverage, 2024 & 2032 (%)
    • 10.1.2. Oncology Cancer
    • 10.1.3. Infectious Diseases
    • 10.1.4. Neurological disorders
    • 10.1.5. Cardiovascular Disorders
    • 10.1.6. Gastrointestinal Diseases
    • 10.1.7. Autoimmune Diseases
    • 10.1.8. Rare Diseases
    • 10.1.9. Others

11. Cell & Gene Therapy Bioanalytical Testing Services Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 11.1.2. Biotechnology & Pharmaceutical Companies
    • 11.1.3. Academic & Research Institutes
    • 11.1.4. Contract Research Organizations (CROs)

12. Cell & Gene Therapy Bioanalytical Testing Services Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Cell & Gene Therapy Bioanalytical Testing Services Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Cell & Gene Therapy Bioanalytical Testing Services Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Cell & Gene Therapy Bioanalytical Testing Services Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Cell & Gene Therapy Bioanalytical Testing Services Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Cell & Gene Therapy Bioanalytical Testing Services Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Cell & Gene Therapy Bioanalytical Testing Services Industry

  • 13.1. Competitive Dashboard
    • 13.1.1. Competitive Benchmarking
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Alliance Pharma
    • 13.2.2. BioAgilytix Labs
    • 13.2.3. Charles River Laboratories
    • 13.2.4. Clean Cells
    • 13.2.5. Covance Inc.
    • 13.2.6. Eurofins Scientific
    • 13.2.7. ICON plc
    • 13.2.8. Intertek Group Plc
    • 13.2.9. IQVIA, Inc.
    • 13.2.10. KCAS Bioanalytical Services
    • 13.2.11. Laboratory Corporation of America Holdings
    • 13.2.12. Pharmaceutical Product Development, Inc. (Thermo Fisher Scientific Inc.)
    • 13.2.13. Pharmaron
    • 13.2.14. Prolytix
    • 13.2.15. SGS SA
    • 13.2.16. Syneos Health
    • 13.2.17. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us